Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cementos Bio-Bio's earnings per share without non-recurring items for the
three
months ended in Dec. 2025 was CLP-75.68.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was CLP-4.13.
During the past 12 months, Cementos Bio-Bio's average earnings per share (NRI) Growth Rate was -103.40% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Cementos Bio-Bio's EPS without NRI or its related term are showing as below:
During the past 13 years, Cementos Bio-Bio's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 28.40% per year. The lowest was -25.80% per year. And the median was -9.85% per year.
XSGO:CEMENTOS's 3-Year EPS without NRI Growth Rate is not ranked *
in the Building Materials industry.
Industry Median: 4.5 * Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
Cementos Bio-Bio's EPS (Diluted) for the
three
months ended in Dec. 2025 was CLP-72.88.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was CLP-0.88.
Cementos Bio-Bio's EPS (Basic) for the
three
months ended in Dec. 2025 was CLP-72.88.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was CLP-0.88.
Cementos Bio-Bio (XSGO:CEMENTOS) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Cementos Bio-Bio EPS without NRI Related Terms
Cementos Bio-Bio EPS without NRI Historical Data
* Premium members only.
The historical data trend for Cementos Bio-Bio's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSGO:CEMENTOS vs CRH, VMC, MLM: EPS without NRI Comparison
For the Building Materials subindustry, Cementos Bio-Bio's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cementos Bio-Bio PE Ratio without NRI vs Building Materials Industry
For the Building Materials industry and Basic Materials sector, Cementos Bio-Bio's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Cementos Bio-Bio's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was CLP-4.13
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cementos Bio-Bio (XSGO:CEMENTOS) has a EPS without NRI of CLP-4.13 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Cementos Bio-Bio and its competitors. According to the industry distribution chart, Cementos Bio-Bio ranks #999999 out of 303 companies in the Building Materials industry.
Is Cementos Bio-Bio's EPS without NRI too high?
Cementos Bio-Bio's current EPS without NRI is CLP-4.13. Based on the distribution chart, Cementos Bio-Bio ranks #999999 out of 303 companies in the Building Materials industry, which is in the bottom quartile relative to peers. Overall, Cementos Bio-Bio has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cementos Bio-Bio's EPS without NRI compare to CRH and VMC?
According to the Building Materials industry distribution chart, Cementos Bio-Bio ranks #999999 out of 303 companies for EPS without NRI. This places Cementos Bio-Bio in the lower half of its industry. The industry median EPS without NRI is 4.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Building Materials company?
The median EPS without NRI among Building Materials companies is 4.50, based on 303 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Cementos Bio-Bio and its competitors. For the Building Materials industry, the median EPS without NRI is 4.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cementos Bio-Bio's current EPS without NRI is CLP-4.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cementos Bio-Bio stock overvalued right now?
Based on GuruFocus' analysis, Cementos Bio-Bio (XSGO:CEMENTOS) is currently considered Significantly Overvalued. The stock's GF Value™ is CLP741.52, compared to a current price of CLP1,730.00 — trading 133.3% above its estimated fair value. The current EPS without NRI is CLP-4.13. Cementos Bio-Bio's overall GF Score™ is 32/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Cementos Bio-Bio (XSGO:CEMENTOS), the current EPS without NRI is CLP-4.13 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cementos Bio-Bio (XSGO:CEMENTOS) Overvalued in 2026?
Based on GuruFocus' analysis, Cementos Bio-Bio stock appears to be overvalued.
The current stock price of CLP1,730.00 is trading 133.3% above its estimated GF Value™ of CLP741.52.
GuruFocus considers Cementos Bio-Bio to be Significantly Overvalued.
Key valuation signals for XSGO:CEMENTOS:
EPS without NRI: CLP-4.13
GF Value™: CLP741.52 vs. price of CLP1,730.00 (133.3% above fair value)
No single metric tells the full story. See the XSGO:CEMENTOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSGO:CEMENTOS has been successfully added to your 
